Enovix Abandons Smartphone Battery Ambitions, Pivots to Drones and Eyewear
Read source articleWhat happened
Enovix has officially abandoned its efforts to enter the smartphone battery market following years of technical setbacks and delays. Interim management will continue developing its proprietary silicon anode technology for the smart eyewear market, and the company's near-term focus has shifted to the drone market, supplied by recently acquired battery technology from South Korea. This strategic reset removes the primary upside driver that underpinned the previous investment thesis, which centered on high-volume smartphone adoption. With smartphones out of the picture, the remaining addressable markets are smaller and less proven, raising questions about Fab2 utilization and the company's path to profitability. The pivot also suggests that management has concluded the smartphone opportunity is not viable in the foreseeable future, a significant departure from earlier positioning.
Implication
Investors should reassess the valuation given that the smartphone market, which drove the most optimistic scenarios, is now off the table. The drone and smart eyewear markets are smaller and may not generate sufficient volumes to justify the current market capitalization or Fab2's fixed costs. Without high-volume smartphone production, Fab2 capacity is likely to remain underutilized, pressuring gross margins and increasing the risk of further capital erosion. While the $648 million cash balance still provides a multi-year runway, the burn may now fund operations with no clear path to profitable scale. Until there is concrete evidence of commercial traction in the new focus areas, maintaining a wait-and-see or reducing exposure is prudent.
Thesis delta
The investment thesis previously rested on the potential for smartphone OEM adoption, with a bull case centered on AI-1 winning flagship designs. With smartphones abandoned, that upside is eliminated, and the base case must be revised downward in terms of revenue growth and margin potential. The rating should shift from WAIT to a more defensive posture, with lowered expectations for Fab2 revenue and increased risk of value impairment.
Confidence
High